Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05660772 · ClinicalTrials.gov registry record · Phase 3

Microfragmented Adipose Tissue Compared to Corticosteroid Injection for the Treatment of Knee Osteoarthritis

A Phase 3 study of Knee Osteoarthritis and Osteo Arthritis Knee, sponsored by Lipogems International spa.

Completed
Registry status
Phase 3
Development phase
173
Enrollment target
18
Study locations

NCT05660772 is a Phase 3 study of Knee Osteoarthritis and Osteo Arthritis Knee that has completed, run by Lipogems International spa. The registered enrollment target is 173 participants, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (43% lower). The trial reports 18 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05660772, a Phase 3 study of Knee Osteoarthritis and Osteo Arthritis Knee, has completed, sponsored by Lipogems International spa.

COMPLETED
Registry status
Phase 3
Development phase
173 participants
Enrollment target
18
Study locations

Study Summary

The goal of this clinical trial is to examine the effect of a single autologous, intra-articular injection of MFat versus corticosteroid injection for the treatment of pain and function associated with K/L grade 2/3 knee Osteoarthritis. Participants will receive an injection of MFat or a corticosteroid.

Conditions Studied

Knee Osteoarthritis Osteo Arthritis Knee

Interventions

  • DRUG Corticosteroid
  • DEVICE Microfragmented Adipose Tissue

Study Locations (18)

Texas

  • All American Ortho - Houston
  • Texas Center for Cell Therapy and Research, LLC - San Antonio
  • San Antonio Orthopedics - San Antonio

California

  • CORE Orthopaedic Center - Encinitas
  • Stanford University - Redwood City

Georgia

  • Pinnacle Trials, Inc - Atlanta
  • Emory University - Brookhaven

New York

  • Northwell Health - New York
  • Columbia University - Tarrytown

Ohio

  • Cincinnati Sports Medicine and Orthopaedic Center - Cincinnati
  • Ohio Health Research Institute - Columbus

Florida

  • Andrews Research & Education Foundation - Gulf Breeze

Iowa

  • University of Iowa Sports Medicine - Iowa City

Maryland

  • Regenerative Orthopedics and Sports Medicine (ROSM) - North Bethesda

Trial Details

FieldValue
Enrollment Target 173 participants
Start Date 2022-12-30
Est. Completion 2025-04-09
Phase Phase 3

Sponsor

Lipogems International spa

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05660772

The ClinicalTrials.gov registry entry for NCT05660772 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 173 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (43% lower). The listed sponsor is Lipogems International spa, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Corticosteroid is the first listed.

NCT05660772 reports 18 study locations spanning 12 distinct geographic areas - top geographies include Texas, California, Georgia.

Frequently Asked Questions

What is clinical trial NCT05660772 about?

NCT05660772 is a clinical study titled "Microfragmented Adipose Tissue Compared to Corticosteroid Injection for the Treatment of Knee Osteoarthritis". The goal of this clinical trial is to examine the effect of a single autologous, intra-articular injection of MFat versus corticosteroid injection for the treatment of pain and function associated with K/L grade 2/3 knee Osteoarthritis. Participants will receive an injection of MFat or a corticoste...

What is the current status of trial NCT05660772?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 173 participants. The study started on 2022-12-30. Estimated completion is 2025-04-09.

What conditions does trial NCT05660772 study?

This clinical trial studies the following conditions: Knee Osteoarthritis, Osteo Arthritis Knee.

What interventions are being tested in trial NCT05660772?

The interventions under investigation include: Corticosteroid (DRUG), Microfragmented Adipose Tissue (DEVICE).

Who is sponsoring clinical trial NCT05660772?

This trial is sponsored by Lipogems International spa, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05660772 being conducted?

This trial has 18 study locations across California, Florida, Georgia, Iowa, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Knee Osteoarthritis

All registered trials for this condition

Osteo Arthritis Knee

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.